ABSTRACT OBJECTIVES This study aimed to explore systolic and diastolic function and to investigate genotype-specific differences in subjects with long QT syndrome (LQTS).
were present in LQTS (5, 6) . A more recent multicenter study reported that differences in mechanical and electrical timing were present in LQTS (7) . However, to the best of our knowledge, comprehensive and detailed assessments of systolic and diastolic function linked to specific ion channel dysfunction have not been performed in LQTS patients previously. Different types of LQTS exist; LQT1 is characterized by dysfunction of the slow potassium channel (I Ks ) (KCNQ1 mutations) (2), whereas LQT2
is characterized by dysfunction of the rapid potassium channel (I Kr ) (KCNH2 mutations) (1) . The cardiac phenotypes in LQT1 and LQT2 are different, with typical exercise-triggered events in LQT1 and emotion-and postpartum-triggered events in LQT2 (8) . To our knowledge, possible mechanical consequences of specific ion channel dysfunction have not previously been studied. Strain echocardiography is a sensitive method for detecting subtle myocardial changes when function is relatively preserved (6, 9, 10) .
We wanted to investigate genotype-specific differences between subjects with LQT1 and LQT2 as different potassium channels are affected. We hypothesized that there is a link between specific ion channel dysfunction and mechanical alterations.
Furthermore, we wanted to explore detailed myocardial mechanics in a large LQTS population compared with healthy controls.
METHODS STUDY POPULATION.
In this cross-sectional study, LQTS mutation-positive subjects were included from our outpatient clinic. Index patients were genetically tested and mutation-positive family members were included by cascade genetic screening. Both singlemutation (n ¼ 183) and double-mutation (n ¼ 9) carriers were included. ELECTROCARDIOGRAPHY. Twelve-lead ECG was obtained at time of the echocardiographic examination. The QT interval was measured by the tangent method and was corrected for heart rate (QTc) by Bazett's formula (11) . Modified QT dispersion was calculated as the time difference between the longest and the shortest QT interval from the precordial leads (12) . T-wave morphology was evaluated for notching (13) and the presence of U waves (14) . and PWTD ¼ posterior wall thickness in diastole) (15) .
We assessed longitudinal strains by speckle tracking echocardiography from 3 apical views at a frame rate >50/s (10). The myocardium was traced in each view, Leren et al. 
RESULTS
A total of 192 subjects with LQTS (age 36 AE 16 years,
117
[61%] female) were included in the study ( Table 1) .
Of the 192, 139 (72%) subjects had LQT1 locus mutations and 53 (28%) had LQT2 locus mutations. Of the 139 subjects with a mutation in the LQT1 locus, 9 (6%)
were double-mutation carriers ( Table 2) . Furthermore, 69 (36%) had LQTS-related symptoms (14 cardiac arrest, 55 syncope) and 123 (64%) were asymptomatic mutation-positive family members (Table 3) . At the time of echocardiographic examination, 75 (39%) subjects with LQTS were taking beta blocker medication. Metoprolol succinate (100 [81,
Leren et al. [10, 20] mg) in 3 (2%) subjects, nadolol (60 mg) in 1 (0.5%) subject, and metoprolol mixture (30 mg) in 1 (0.5%) subject.
In addition to beta blocker therapy, 19 (10%) patients with LQTS were treated with an implantable cardioverter-defibrillator, 7 (4%) with a singlechamber atrial pacemaker, and 1 (0.5%) with left sympathetic cardiac denervation.
We included 60 healthy persons ( (Figure 1 ), also when adjusted for age, gender, heart rate, BSA, LV mass, blood pressure, and enddiastolic volume ( Table 1 ) and in separate analyses of beta blocker-naïve subjects (Online Table 1 ).
Importantly, this result was driven by reduced systolic function by GLS in LQT2. Subjects with LQT2
had worse GLS compared with subjects with LQT1
(p ¼ 0.01) ( Figure 2 ). This result remained significant also in analyses of only beta blocker-naïve subjects (n ¼ 94) (LQT2: GLS À20.8 AE 1.8%, vs. LQT1:
02). GLS in subjects with
LQT1 did not differ from GLS in healthy controls (p ¼ 0.11) (Figure 2 ).
Contraction duration was longer in subjects with
LQTS than in healthy controls (p < 0.001) ( Table 1) ,
and it was even longer in symptomatic compared with asymptomatic subjects with LQTS (p < 0.001) ( Table 3 ). In subjects with LQTS, contraction duration was 32 ms shorter than the QT interval. In other words, the electromechanical time difference was À32 AE 46 ms, whereas healthy persons had a longer contraction duration than QT interval, thus giving a BSA ¼ body surface area; CI ¼ confidence interval; e 0 ¼ early diastolic myocardial velocity; E/A ¼ ratio between early and atrial transmitral flow velocities; EDV ¼ enddiastolic volume; E/e 0 ¼ ratio between early transmitral filling velocity and early diastolic myocardial velocity; EF ¼ ejection fraction; GLS ¼ global longitudinal strain; IVRT ¼ isovolumic relaxation time; LAVI ¼ left atrial volume index; LQTS ¼ long QT syndrome; QTc ¼ QT interval corrected for heart rate.
time difference of 8 AE 32 ms (p < 0.001) ( Table 1) .
The electromechanical time difference was more pronounced in the symptomatic subjects with LQTS compared with asymptomatic subjects (p ¼ 0.04) ( Table 3) . Mechanical dispersion, reflecting heterogeneous contraction, was more pronounced in the subjects with LQTS compared with healthy controls (p < 0.001) ( Table 1) , and it was most pronounced in symptomatic patients with LQTS (p < 0.001) ( Table 3) .
Results were similar for all systolic measures in beta blocker-naïve subjects (Online Table 1 Figure 3 ). IVRT and E deceleration times were longer and LAVI was larger in subjects with LQTS (all p < 0.01). The diastolic parameters e 0 , IVRT, and LAVI were altered in LQTS also when adjusted for age, gender, heart rate, BSA, LV mass, blood pressure, and end-diastolic volume ( Table 1) . Age-grouped analyses showed that LAVI was increased only in age group 41 to 60 years (p ¼ 0.001) ( Table 4) . Beta blocker-naïve subjects with LQTS showed similarly decreased diastolic function (Online Table 1 ). No differences in diastolic parameters were observed between LQT1 and LQT2. Abbreviations as in Table 1 . Abbreviations as in Table 1 .
SYSTOLIC MYOCARDIAL CHANGES IN LQTS. Systolic myocardial function by GLS was lower in subjects
with LQTS compared with healthy controls, adjusted for possible confounders (19, 20) and also in the subgroup of beta blocker-naïve subjects with LQTS. This In the total LQTS population only parameters of myocardial timing were markers of arrhythmic Average systolic function was lower in long QT syndrome (LQTS) compared with healthy controls, and this difference was mainly the result of the changes in subjects with LQT2.
Leren et al. A subset of our patients fulfilled the echocardiographic diastolic criteria for heart failure with preserved EF. However, none of our patients had symptoms of heart failure. We believe that the dia- A subset of subjects was treated with beta blocker medication at the time of echocardiographic examination. Therefore, all analyses were additionally adjusted for heart rate, and beta blocker-naïve subjects were analyzed separately with unchanged results. Therefore, our findings could not be attributed to the use of beta blocker medication. The observed alterations were subtle, and the importance for clinical outcome has not been elucidated.
In addition, the correlation between mechanical and electrical parameters and the underlying mechanisms ACKNOWLEDGMENTS The authors thank all participants in this study. 
